Today: 10 April 2026

NV Energy Stock Holds Steady Amid Nevada Utility Turmoil

NV Energy Stock Holds Steady Amid Nevada Utility Turmoil

NV Energy shares traded near $23.74 on Oct. 24, 2025, with very low volume and warnings of possible delisting. In September, Nevada regulators approved a new rate plan adding daily demand charges and stricter solar net-metering, drawing protests from solar groups. On Oct. 20, FERC rejected NV Energy’s requests to ease grid interconnection penalties for renewable developers.
24 October 2025
Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr shares surged over 25% on October 24 after its two largest shareholders proposed an $18 per share buyout, valuing the company at a 51% premium to pre-offer prices. Board chair James Lu and director Ray Zage, controlling about 60% of shares, submitted the non-binding bid and say financing is secured. Grindr’s board formed a special committee to review the offer. Trading volume spiked to nearly 6 million shares.
Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Clover Health stock surged nearly 18% to about $3.79 on Oct. 24, with trading volume exceeding 15 million shares, far above its average. The price broke past both its 50-day and 200-day moving averages. Zacks upgraded the stock to Buy on Oct. 23, but overall analyst consensus remains Hold, with a 12-month price target averaging $4.03. Short interest stands at roughly 12.9% of float.
24 October 2025
Western Union Stock Edges Up on Q3 Beat – CEO Calls Crypto an “Opportunity”

Western Union Stock Edges Up on Q3 Beat – CEO Calls Crypto an “Opportunity”

Western Union shares traded near $8.15 on Oct. 23, up 0.4% after Q3 results beat adjusted EPS estimates. Q3 revenue was $1.03 billion, flat year-over-year, with digital and consumer services driving growth. WU agreed to buy Intermex for $500 million and struck new fintech partnerships. Analysts remain cautious, citing competition and execution risks despite a high dividend yield.
24 October 2025
Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics (TOVX) Stock Surges on Cancer Trial Breakthrough – What’s Next?

Theriva shares surged 92% intraday Oct. 15 after its VCN-01 therapy met primary endpoints in a Phase 2b pancreatic cancer trial, then fell back following a $4 million equity raise. Median survival in a two-dose subgroup reached 14.8 months versus 11.6 for chemo alone. The company held $12.1 million cash as of June 30, 2025, funding operations into early 2026. Expanded trial results will be presented at ESMO Oct. 20.
24 October 2025
The $350B Shake-Up: How AI Summaries Rewire Publisher Traffic

Alphabet Stock Skyrockets to Record High, Nears $3 Trillion on AI Boom & Earnings Hype

Alphabet Inc. hit a record near $260 per share on Oct. 24, pushing its market value to about $3.1 trillion. The stock rebounded after a volatile week, buoyed by a breakthrough quantum computing announcement and a major cloud deal with Anthropic. Analysts raised price targets, with several now above $290. Alphabet reports Q3 earnings Oct. 29.
MultiSensor AI Stock’s Wild Ride: +42% Rally on Major Deal, –50% Crash After $14M Funding

MultiSensor AI Stock’s Wild Ride: +42% Rally on Major Deal, –50% Crash After $14M Funding

MultiSensor AI shares jumped up to 100% on Oct. 23 after announcing a major U.S. deployment deal, then plunged nearly 50% the next day following news of a $14 million private share placement at $0.409 per share. As of Oct. 24 midday, the stock traded near $0.73, down 47% on the day and 32% below last year. Institutions own 82% of shares. Full-year 2024 revenue was $7.4 million with a $21.5 million net loss.
Adverum (ADVM) Stock Skyrockets on News of Lilly’s $12.47/Share Gene Therapy Deal

Adverum (ADVM) Stock Skyrockets on News of Lilly’s $12.47/Share Gene Therapy Deal

Eli Lilly said Oct. 24 it will buy Adverum Biotechnologies for $3.56 per share plus a CVR worth up to $8.91, targeting Adverum’s lead gene therapy Ixo-vec for wet AMD. Adverum shares jumped 17% on the news but stayed well below the $12.47 maximum deal value. The agreement includes a $65 million secured loan to fund trials before closing. Adverum had warned its cash would run out by Q4 2025.
Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Neuphoria shares plunged about 67% in after-hours trading Oct. 20 after its lead drug BNC210 failed a Phase 3 trial for social anxiety disorder. The company halted its social anxiety program, began a strategic review, and said it would cut spending. NEUP stock dropped from $15.40 to near $4.05 before rebounding to $6.70 by Oct. 24. Neuphoria reported $14.2 million in cash as of June 30 and maintains a partnership with Merck.
24 October 2025
Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash?

Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash?

Picard Medical stock plunged about 75% to $3.27 by mid-day Oct. 24, after hitting a 52-week high of $13.68 the previous day. The selloff followed an SEC filing authorizing up to 18 million new shares, raising dilution fears. The company recently reported 207% Q2 revenue growth and completed a $19.5 million IPO in September. Analysts cite uncertainty over future growth and dilution.
24 October 2025
General Dynamics Stock Rockets to Record High on Blowout Q3 Results and Defense Windfall

General Dynamics Stock Rockets to Record High on Blowout Q3 Results and Defense Windfall

General Dynamics reported Q3 2025 revenue of $12.91 billion, up 10.6% year-over-year, and EPS of $3.88, beating forecasts. Gulfstream jet deliveries rose to 39 from 28, driving a 30% jump in aerospace revenue. The company ended the quarter with a $167.7 billion backlog and won major new defense contracts. GD shares climbed to around $353 after hours, up 27% year-to-date.
NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

NeurAxis announced FDA 510(k) clearance for its PENFS device to treat adult functional dyspepsia on Oct. 24, marking the first approved therapy for this condition. NRXS shares rose to $3.82 on Oct. 23 and traded higher pre-market after the news. The company recently raised $5 million and expanded insurance coverage to 53 million lives. Q2 revenue grew 46% year-over-year; analyst sentiment remains mixed.
24 October 2025
Bond Yields Plunge on Cooling Inflation – Fed Cuts and Stock Rally in Play?

Bond Yields Plunge on Cooling Inflation – Fed Cuts and Stock Rally in Play?

U.S. consumer inflation rose 3.0% year-on-year in September, slightly below forecasts, prompting markets to fully price in a Fed rate cut next week. The 10-year Treasury yield fell below 4% and the dollar weakened on the news. S&P 500 futures jumped about 1%, lifting stocks toward record highs. Financials outperformed, while homebuilders and utilities lagged.
Stocks Rocket on Cooling Inflation Data; Tech Stocks & Fed Speeches in Spotlight

Stocks Rocket on Cooling Inflation Data; Tech Stocks & Fed Speeches in Spotlight

US September CPI rose 3.0% year-on-year, below the 3.1% forecast, fueling a Wall Street rally and bets on a Fed rate cut next week. Nasdaq gained 0.9%, S&P 500 rose 0.6%, and Dow added 0.3% on October 23. Philadelphia Fed manufacturing index plunged to −12.8 in October from +23.2. Oil prices spiked on new sanctions, while gold eased from record highs.
Retirement Alert: 90% of Americans Are Giving Up Big Social Security Checks (Act Now Before It’s Too Late!)

Retirement Alert: 90% of Americans Are Giving Up Big Social Security Checks (Act Now Before It’s Too Late!)

Nine in ten U.S. workers plan to claim Social Security before age 70, despite warnings that waiting could increase lifetime payouts by about $182,000. Nearly 87% of non-retired Americans worry about having enough retirement income, and over half fear outliving their savings. The 2026 Social Security COLA is forecast at 2.6–2.8%, but rising Medicare and living costs will offset much of the increase.
Stocks Rally as U.S. Inflation Cools – Asia Joins Global Rally, Fed Cut Seen as Lock

Stocks Rally as U.S. Inflation Cools – Asia Joins Global Rally, Fed Cut Seen as Lock

U.S. consumer prices rose 0.3% in September, below forecasts, with core CPI up 0.2%. Wall Street futures climbed after the data; Dow E-mini futures gained 0.5%, S&P 500 E-minis 0.7%, and Nasdaq 100 E-minis 0.98%. Intel surged 8% pre-market on strong earnings, while Deckers Outdoor dropped 11.5% after cutting guidance. Fed futures now price in a 25bp rate cut at next week’s meeting.
Billionaire Larry Ellison’s Fortune Plummets: Oracle Share Slump Wipes Out $24B

Billionaire Larry Ellison’s Fortune Plummets: Oracle Share Slump Wipes Out $24B

Oracle shares fell 7% on Oct. 17 and nearly 5% on Oct. 20, erasing about $38 billion from Larry Ellison’s net worth. The stock closed near $280 on Oct. 23, down from September highs but still up roughly 70% year-to-date. Ellison remains the world’s second-richest person at $336–351 billion. Analysts’ price targets for Oracle range widely, with some citing risks tied to its AI rollout.
24 October 2025

Stock Market Today

  • Nasdaq Short Interest Rises Across Global Market Securities as of March 31, 2026
    April 10, 2026, 5:23 PM EDT. Nasdaq reported an increase in short interest, the total shares sold short but not yet covered, across its securities as of March 31, 2026. Short interest on the Nasdaq Global Market rose to 16.51 billion shares from 16.18 billion on March 13, marking 2.73 days of average daily volume, up from 2.42 days. On the Nasdaq Capital Market, short interest increased to 3.88 billion shares with 1.30 days average daily volume, compared to 3.79 billion shares and 1.23 days previously. Overall, short interest across all 5,336 Nasdaq securities climbed to 20.39 billion shares, or 2.26 days average daily volume, up from 19.97 billion shares and 2.05 days. Nasdaq is a major technology company providing market infrastructure and data services globally.

Latest article

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

10 April 2026
London’s FTSE 100 rose 0.38% to 10,644.28 late Friday morning as investors awaited U.S.-Iran talks in Pakistan. Brent crude climbed 1% to $96.83 a barrel, while sterling eased but was on track for its biggest weekly gain since January. The FTSE 250 gained 0.79%. Britain’s 10-year gilt yield stood at 4.807%.
US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

10 April 2026
Dow e-minis slipped 0.15% before Friday’s open, with S&P 500 and Nasdaq 100 futures each down 0.08% as traders awaited March CPI data and watched U.S.-Iran tensions. Economists expect headline CPI to rise 0.9% for March and 3.3% year-on-year. Weekly jobless claims increased to 219,000. Brent crude traded near $97 a barrel, while shipping through the Strait of Hormuz remained well below normal.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 5:33 PM EDT Nasdaq Short Interest Rises Across Global Market Securities as of March 31, 2026 April 10, 2026, 5:23 PM EDT. Nasdaq reported an increase in **short interest**, the total shares sold short but not yet covered, across its securities as of March 31, 2026. Short interest on the Nasdaq Global Market rose to 16.51 billion shares from 16.18 billion on March 13, marking 2.73 days of average daily volume, up from 2.42 days. On the Nasdaq Capital Market, short interest increased to 3.88 billion shares with
MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
Go toTop